A Phase II Double-blind and Randomized Trial Comparing Concurrent Chemoradiotherapy Plus PG2 Injection Versus Concurrent Chemoradiotherapy Plus Placebo in Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2015
At a glance
- Drugs PG 2 (Primary)
- Indications Fatigue
- Focus Therapeutic Use
- Sponsors PhytoHealth
- 03 Nov 2015 Status changed from recruiting to discontinued, according to ClinicalTrials.gov record.
- 29 Apr 2015 New trial record
- 27 Apr 2015 Planned End Date changed from 1 Oct 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov record.